Orizuru Therapeutics Launches Operations Focusing on Induced Pluripotent Stem Cell (iPSC) Regenerative Medicine
The new company is expected to advance two successful outcomes from T-CiRA collaboration for severe heart failure and Type 1 Diabetes to clinical application of iPSC-based medicine. In June 2021,...